Clinical Trial Update: Phase 1 Safety and Immunogenicity of Meningococcal Vaccine [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety and immunogenicity of a meningococcal vaccine targeting Group B; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Infection Group

Drugs mentioned

• Meningococcal vaccine (Group B)

Snippet

Sponsor: U.S. Army Medical Research and Development Command | Conditions: Meningococcal Infection, Group B | Phase 1 | Status: COMPLETED | Results posted: 2017-12-18